migA (PA0705, Q9I5M1) notes

Literature (own research, 2026-11-05)

PseudoCAP IBA-seed assessment

PTN node node term n_seeds leaf IBAs seed annotation (term, evidence, PMID) verdict rationale other seeds IBD stands without this seed?
PTN000531320 GO:0016757 glycosyltransferase activity 7 44 (17 taxa) GO:0016757, IDA, PMID:18178733 SOUND Specific loss of alpha-1,6-L-Rha in the mutant supports MigA as the transferase (evidence is mutant structure rather than an enzyme assay). Salmonella RfbV P26401 (GO:0047600 IDA), E. coli WcaA P77414 (GO:0015020 IDA), Mtb Rv2957 P9WMX7 (GO:0016758 IDA), B. subtilis SunS O31986 (GO:0008194 IDA), P. aeruginosa PA1014 Q9I4V9 (GO:0008919 IDA), WapR Yes
PTN000531351 GO:0009244 lipopolysaccharide core region biosynthetic process 2 18 (10 taxa) GO:0009244, IMP, PMID:18178733 SOUND Mutant LPS structure (NMR/MS) lacks the sugar MigA adds. WapR Q9HUG5 only (PseudoCAP IMP/IDA) Yes, on WapR alone; but the node term does not suit the clade (see below)

Node-level GO_CENTRAL defect for PTN000531351 is recorded once, on genes/PSEAE/wapR (WapR IBA row): the clade's leaves include Salmonella RfbV (O-antigen abequosyltransferase) and E. coli WcaA (colanic acid), whose experimental annotations contradict an LPS-core term. Not repeated here.

PseudoCAP defect: GO:0015920 lipopolysaccharide transport (IDA, PMID:19589832) WRONG_TERM, PROBABLE.

Action counts

ACCEPT 2, MODIFY 2, MARK_AS_OVER_ANNOTATED 1, REMOVE 1.